Catalent is hiring across our Gene Therapy sites in Maryland! At Harman’s, we have a state-of-the-art cGMP, clinical through commercial gene therapy manufacturing facility. We are located just 5 miles [….]
CATALENT PHARMA SOLUTIONS IN-PERSON HIRING EVENT
Catalent is hiring across our Gene Therapy sites in Maryland! At Harman’s, we have a state-of-the-art cGMP, clinical through commercial gene therapy manufacturing facility. We are located just 5 miles [….]
Life Science Development Projects Position Baltimore BioMed Ecosystem for Boom
The Baltimore biotech ecosystem is thriving. And new, big and bold life sciences development projects are in the works, leading many to project Charm City as the next sector of the BioHealth Capital Region (BHCR) to boom.
5 Questions with Geeta Peverada, Ph.D., P.M.P., Program Manager, Quality Control at Catalent Pharma Solutions
Geeta Peverada is a highly motivated, data-driven, and goal-oriented program management professional with over 12 years of experience in cancer research and gene therapy. She is bridging the gap between science and business through her expertise in client management and scientific knowledge. Her analytical, leadership, and management expertise has led to strengthened client partnerships at her current organization, Catalent Pharma Solutions.
PODD: Partnership Opportunities in Drug Delivery
Published on :Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug [….]
Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland
Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland
AstraZeneca in Talks to Shift Coronavirus Vaccine Production to Catalent’s Maryland Factory
AstraZeneca is reportedly in talks to shift production of its coronavirus vaccine to a Maryland-based factory operated by Catalent, Inc.
AavantiBio and Catalent Announce Partnership to Support Development and Manufacturing of Gene Therapies for Rare Genetic Diseases
Partnership to advance AavantiBio’s diversified gene therapy pipeline, including the Company’s lead program in Friedreich’s Ataxia (FA)
Biohealth Industry Day Highlights Partnerships and Pathways for Early-Career Professionals
While the pandemic has forced many industries to downsize, biotech companies have had the opportunity — or sometimes the obligation — to ramp up. Just take a look at Catalent Pharma Solutions, the Baltimore-based contract manufacturer. The company has hired over 500 new employees since last March, said Talent Acquisition Specialist Charle’ Lamb during a panel at the Biohealth Industry Day.
2020’s Top 10 Most Read News Stories from the BioHealth Capital Region
2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.